Walleye Capital
CABA icon

Walleye Capital’s Cabaletta Bio CABA Stock Holding History

Walleye Capital’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-110,988
Closed -$252K – 4304
2024
Q4 		$252K Sell
110,988
-290,994
-72% -$1.02M ﹤0.01% 3573
2024
Q3 		$1.9M Buy
401,982
+212,025
+112% +$1.23M ﹤0.01% 1998
2024
Q2 		$1.42M Buy
+189,957
New +$2.33M ﹤0.01% 2466
2023
Q1 		– Sell
-60,505
Closed -$560K – 3953
2022
Q4 		$560K Buy
+60,505
New +$220K 0.01% 1373
2022
Q2 		– Sell
-30,507
Closed -$62K – 2381
2022
Q1 		$62K Sell
30,507
-45,272
-60% -$118K ﹤0.01% 1822
2021
Q4 		$287K Buy
+75,779
New +$809K 0.01% 1272

Other funds holding CABA

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Walleye Capital's CABA Position: Q1 2025 in Review

Walleye Capital sold out of Cabaletta Bio (CABA) in Q1 2025, closing a stake of 110,988 shares — an estimated $252K sold.

Walleye Capital first reported a position in CABA in Q4 2021 and held it in 6 quarters. The position peaked at $1.9M in Q3 2024. 92 funds tracked by Wall St. Rank hold CABA as of Q1 2025.

  • Walleye Capital reported no remaining Cabaletta Bio position as of Q1 2025 after selling out during the quarter.
  • Walleye Capital sold 110,988 Cabaletta Bio shares in Q1 2025, an estimated $252K.
  • Walleye Capital first reported a position in Cabaletta Bio in Q4 2021 and held it in 6 quarters.
  • Walleye Capital's Cabaletta Bio position peaked at $1.9M in Q3 2024.
  • 92 funds tracked by Wall St. Rank held Cabaletta Bio as of Q1 2025.

Based on Walleye Capital's 13F filing for Q1 2025, filed 14 May 2025.